Eslicarbazepine Acetate
28 NDCs across 7 manufacturers|24 Generic,4 Brand
Eslicarbazepine Acetate is used to treat seizures, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 8, 2013, and the first generic was approved Jun 29, 2021. FDA's Orange Book lists 40 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $144 million on Eslicarbazepine Acetate across 84,000 claims for 8,265 beneficiaries.
Eslicarbazepine Acetate is available as 28 NDCs from 7 manufacturers (24 generic, 4 brand), with NADAC prices from $1.68 to $44.43 per EA — the most expensive product costs about 27× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
28
24G / 4B
Manufacturers
7
competing in market
Price Spread
$1.68 – $44.43
per EA
7d Activity
avg -9.2% WoW · of 28 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sumitomo Pharma America, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing ESLICARBAZEPINE ACETATE(1 pricing outlier)
Frequently Asked Questions
What is Eslicarbazepine Acetate used to treat?
Eslicarbazepine Acetate is used to treat seizures, per the National Library of Medicine's MED-RT classification.
When did Eslicarbazepine Acetate become available as a generic?
FDA approved the first generic Eslicarbazepine Acetate (ANDA) on Jun 29, 2021. The Orange Book currently lists 40 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Eslicarbazepine Acetate?
In 2024, Medicare Part D spent $144 million on Eslicarbazepine Acetate across 84,000 claims for 8,265 beneficiaries.
How many Eslicarbazepine Acetate products are on the market?
The Eslicarbazepine Acetate drug market contains 28 NDCs from 7 manufacturers — 24 generic and 4 brand products.
What is the price range for Eslicarbazepine Acetate?
NADAC reference prices for Eslicarbazepine Acetate range from $1.6758 to $44.4261 per EA — the most expensive product costs about 27× the cheapest.
Is generic Eslicarbazepine Acetate cheaper than brand?
The average generic NADAC for Eslicarbazepine Acetate is $1.8940 per EA, versus $44.2107 for brand-labeled products — brand versions average about 23× the generic price.
Which manufacturers make Eslicarbazepine Acetate?
7 manufacturers list Eslicarbazepine Acetate in NADAC. Ranked by number of NDCs, the largest are Sumitomo Pharma America, Inc. (4), Apotex Corp. (4), Torrent Pharmaceuticals Limited (4), Camber Pharmaceuticals Inc. (4), Dr. Reddy's Laboratories Inc. (4).
How has the price of Eslicarbazepine Acetate changed recently?
Over the past 7 days, 7 Eslicarbazepine Acetate NDCs rose and 20 fell, with a market-wide average change of -9.2%.